Dose and schedule as determinants of outcomes in chemotherapy for breast cancer
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 31, 3-9
- https://doi.org/10.1053/j.seminoncol.2004.11.021
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomasLaboratory Investigation, 2004
- Classification of Human Breast Cancer Using Gene Expression Profiling as a Component of the Survival Predictor AlgorithmClinical Cancer Research, 2004
- Molecular profiling of breast cancer: clinical implicationsBritish Journal of Cancer, 2004
- Incidence and Predictors of Low Dose-Intensity in Adjuvant Breast Cancer Chemotherapy: A Nationwide Study of Community PracticesJournal of Clinical Oncology, 2003
- How to calculate the dose of chemotherapyBritish Journal of Cancer, 2002
- Theoretical Concepts and the Emerging Role of Taxanes in Adjuvant TherapyThe Oncologist, 2001
- Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer.Clinical Pharmacokinetics, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Kinetic Concepts in the Treatment of Breast CancerPublished by Springer Nature ,1993